MyAverix Finance
F · Healthcare
ABIONYX PHARMA SA EO-05 (609)
Biotechnology
ABIONYX PHARMA SA EO-05 (609) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 609
ABIONYX PHARMA SA EO-05 (609) — FAQ
What is 609's P/E ratio?
The price-to-earnings (P/E) ratio for ABIONYX PHARMA SA EO-05 (609) is 25.00 (data as of 2026-05-23).
Does ABIONYX PHARMA SA EO-05 pay a dividend?
Dividend yield is not available in the current snapshot for ABIONYX PHARMA SA EO-05 (609). Check the MyAverix Finance app for the latest dividend data.
What sector is ABIONYX PHARMA SA EO-05 in?
ABIONYX PHARMA SA EO-05 (609) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 609 listed on?
609 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.